Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology | Family Medicine | Gynecology | Internal Medicine | Nursing | Pharmacy | Journal

Back to Journal Articles

Antihypertensive Use in Pregnancy Increasing

Last Updated: September 10, 2012.

 

Prevalence close to 5 percent; some medications contraindicated in pregnancy are still used

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
The prevalence of antihypertensive use in pregnancy is approaching 5 percent and is increasing, according to a study published online Sept. 10 in Hypertension.

MONDAY, Sept. 10 (HealthDay News) -- The prevalence of antihypertensive use in pregnancy is approaching 5 percent and is increasing, according to a study published online Sept. 10 in Hypertension.

Brian T. Bateman, M.D., from Brigham and Women's Hospital in Boston, and colleagues analyzed maternal exposure to antihypertensive medications using data from Medicaid pharmacy claim files from 2000 to 2007, creating a cohort of 1,106,757 Medicaid patients.

Of the participants, 4.4 percent (48,453 women) were exposed to antihypertensive medications during pregnancy. The researchers found that during the study period the prevalence of antihypertensive use increased from 3.5 to 4.9 percent. Compared to nonusers, users of antihypertensive medications were older, more likely to be white or black, and more likely to have comorbid diabetes mellitus and renal disease. Exposure to antihypertensives was noted for 1.9 percent of pregnant women during the first trimester, 1.7 percent during the second trimester, and 3.2 percent during the third trimester. Patients were exposed to a wide range of antihypertensive medications. Angiotensin-converting enzyme inhibitors, which are contraindicated in late pregnancy, were used by 4.9 percent of users in the second trimester and 1.1 percent in the third trimester.

"Our data suggest that the exposure to antihypertensive medications in pregnancy is relatively common and increasing," the authors write. "Research investigating the comparative safety and efficacy of antihypertensive therapy in pregnancy is urgently needed to define the optimal approach to therapy."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Cancer Survivors Uneasy With Primary Care Doctor Follow-Up Next: NSAID Use Ups Cardiovascular Risk Up to Five Years Post-MI

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.